CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more ...

CVS Health CVS has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance ...

Investors seeking both growth and income may want to take a closer look at CVS Health stock. The diversified ... the company raised its full-year earnings outlook. It predicted earnings of $6 ...

The pharmacy chain modestly lowered its full-year outlook ... stock pulling back in response today. Steve Symington has no position in any of the stocks mentioned. The Motley Fool recommends CVS ...

The 10x P/E ratio aligns with the stock’s last five-year average. The company reiterated its 2023 earnings outlook in the $8.50 to $8.70 range. CVS Health’s revenue of $89.8 billion in Q3 was ...

The big reason for the revised outlook is rising ... And with CVS' health insurance business, Aetna, being a key part of its operations, the stock hasn't been able to avoid the effects of that.

CVS stock surged Tuesday after ... after the company improved its full-year outlook and named a new chief financial officer. The pharmacy and health insurance giant said it now expects to meet ...

S&P changed the outlook on the Company’s long-term debt from “Positive” to “Stable.” CVS says it has repaid $25.2bn of long-term debt since making its ~$70bn acquisition of health ...

Although the adjusted EPS outlook for UnitedHealth ... whether investors feel strongly about the stock one way or another. In the past 3 months, CVS Health rose 6.3%, which indicates that opinion ...

As such, the Zacks rating upgrade for CVS Health is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company's future ...